Trial intelligence / Profile preview

Entonox alone versus Entonox plus magnesium sulfate for labor analgesia in mild preeclampsia

IRCT20200302046666N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of nitrous oxide + oxygen and magnesium sulfate in preeclampsia (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Pain severity. Started Apr 2020; status: completed.

02

Drugs

nitrous oxide + oxygenmagnesium sulfate
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT20200302046666N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200302046666N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call